At a glance
- Originator University of Alabama
- Class Antivirals
- Mechanism of Action Neuraminidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 03 Oct 2001 Discontinued-Preclinical for Influenza virus infections in USA (PO)
- 04 May 2001 Ortho-McNeil and RW Johnson have given 4 months' notice that they intend to terminate their research agreement with BioCryst
- 19 Feb 2001 A preclinical study has been added to the Viral Infections antimicrobial activity section